Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group Limited (3320.HK)

Industry: Drug Manufacturers - Specialty & Generic Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $14.55 — $74.50
Selected (Average) $35.51
Upside to Live 682.08%
Full Range Fair Value
Range (Low - High) $15.76 — $77.37
Selected (Average) $40.36
Upside to Live 789.06%
Live Price $4.54

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
CPHI 1 China Pharma Holdi 107,330 - - 0.00 0.00 - -
3320.HK 2 China Resources Ph 71,370 4.54 4.79 3.31 2.85 3.23 3.53
4541.T 3 Nichi-Iko Pharmace 58,463 0.42 0.20 -2.85 -1.20 -2.49 -4.65
4502.T 4 Takeda Pharmaceuti 28,374 209.34 232.70 9.75 9.01 40.15 24.79
HLN.L 5 Haleon plc 14,738 22.28 22.28 14.98 14.98 17.36 18.50
VTRS 6 Viatris Inc. 14,124 - - - - 26.65 -
600332.SS 7 Guangzhou Baiyunsh 11,005 13.91 13.62 11.54 11.07 11.94 13.29
8129.T 8 Toho Holdings Co., 9,838 16.75 14.74 7.34 6.75 18.91 12.32
HIK.L 9 Hikma Pharmaceutic 8,337 9.28 8.96 5.32 4.93 7.14 5.84
IPN.PA 10 Ipsen S.A. 8,202 7.41 5.66 3.15 2.33 3.08 3.87
600511.SS 11 China National Med 7,373 10.73 10.17 7.71 7.62 7.32 6.49
000963.SZ 12 Huadong Medicine C 6,116 19.69 18.88 14.52 13.45 16.80 15.93
SUNPHARMA.BO 13 Sun Pharmaceutical 6,083 36.61 24.73 22.68 19.18 27.88 13.88
BHC 14 Bausch Health Comp 5,991 6.61 6.61 4.62 4.24 8.93 11.65
PPD 15 PPD, Inc. 5,879 45.17 45.17 21.41 21.41 26.16 30.08
000538.SZ 16 Yunnan Baiyao Grou 5,781 19.47 19.24 18.67 17.68 19.69 15.25

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple13.9113.627.717.6216.8012.80
Full Range Median Multiple16.7514.749.759.0117.3613.58
Industry Multiple32.1332.5310.9010.2117.8514.32
Market Implied Multiple4.034.253.192.753.113.40
Company (3320.HK) Multiple4.544.793.312.853.233.53
(*) Net Income / EBITDA / Revenue9128654,0354,6824,1353,783
Winsorized Enterprise ValueN/AN/A31,09835,68569,47648,438
Full Range Median Enterprise ValueN/AN/A39,32242,21271,79651,376
(-) Net Debt9,2029,2029,2029,2029,2029,202
Winsorized Equity Value12,69111,77521,89626,48260,27439,236
Full Range Median Equity Value15,28712,74830,12033,01062,59442,174
(/) Shares Outstanding809809809809809809
Winsorized Fair Value$15.69$14.55$27.06$32.73$74.50$48.50
Full Range Median Fair Value$18.90$15.76$37.23$40.80$77.37$52.13
Current Price$4.54$4.54$4.54$4.54$4.54$4.54
Upside / Downside245.51%220.58%496.14%621.00%1,541.00%968.23%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$10.98$10.19$18.95$22.91$52.15$33.95
Buy / Don't BuyBUYBUYBUYBUYBUYBUY